Skip to news
JQJO
Latest

FDA Cracks Down on Telehealth Drug Ads | JQJO

FDA Cracks Down on Telehealth Drug Ads

FDA Cracks Down on Telehealth Drug Ads

Tap title to read story

0:00 / 0:42

The FDA issued over 100 warning letters to telehealth companies, including Hims & Hers, for promoting unapproved, compounded versions of prescription weight-loss drugs like Wegovy and Ozempic. The letters, part of a broader crackdown on pharmaceutical advertising, allege false and misleading claims that these compounded medications are equivalent to FDA-approved drugs. Hims & Hers stated they will cooperate with the FDA. This action marks the FDA's first direct attempt to regulate online platforms promoting such products, following a recent White House directive to ensure truthful pharmaceutical advertising.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Lakers Edge Kings 106-104

Tap title to read story

0:00 / 0:41

Oregon Rout Michigan State 45‑7

Tap title to read story

0:00 / 0:40

Chiefs Add Josh Downs, Seek More

Tap title to read story

0:00 / 0:00

Oregon Ducks Lose Hill to Injury

Tap title to read story

0:00 / 0:35

Clemson QBs Beat Duke 20-10

Tap title to read story

0:00 / 0:42

Kings Mountain Wins 41‑18 Over

Tap title to read story

0:00 / 0:44

JQJO

Find your next story

Search JQJO’s current coverage.